[1]
|
Mildh, L., Hiippala, A., Rautiainen, P., Pettila, V., Sairanen, H. and Happonen, J.M. (2011) Junctional Ectopic Tachycardia after Surgery for Congenital Heart Disease: Incidence, Risk Factors and Outcome. European Journal of Cardio-Thoracic Surgery, 39, 75-80. https://doi.org/10.1016/j.ejcts.2010.04.002
|
[2]
|
Cools, E. and Missant, C. (2014) Junctional Ectopic Tachycardia after Congenital Heart Surgery. Acta Anaesthesiologica Belgica, 65, 1-8.
|
[3]
|
Collins, K.K., Van Hare, G.F., Kertesz, N.J., Law, I.H., Bar-Cohen, Y., Dubin, A.M., et al. (2009) Pediatric Nonpost-Operative Junctional Ectopic Tachycardia Medical Management and Interventional Therapies. Journal of the American College of Cardiology, 53, 690-697. https://doi.org/10.1016/j.jacc.2008.11.019
|
[4]
|
Villain, E., Vetter, V.L., Garcia, J.M., Herre, J., Cifarelli, A. and Garson Jr., A. (1990) Evolving Concepts in the Management of Congenital Junctional Ectopic Tachycardia. A Multicenter Study. Circulation, 81, 1544-1549.
https://doi.org/10.1161/01.CIR.81.5.1544
|
[5]
|
Bois, P., Bescond, J., Renaudon, B. and Lenfant, J. (1996) Mode of Action of Bradycardic Agent, S 16257, on Ionic Currents of Rabbit Sinoatrial Node Cells. British Journal of Pharmacology, 118, 1051-1057.
https://doi.org/10.1111/j.1476-5381.1996.tb15505.x
|
[6]
|
Batra, A.S., Chun, D.S., Johnson, T.R., Msaldonado, E.M., Kashyap, B.A., Malers, J., et al. (2006) A Prospective Analysis of the Incidence and Risk Factors Associated with Junctional Ectopic Tachycardia Following Surgery for Congenital Heart Disease. Pediatric Cardiology, 27, 51-55. https://doi.org/10.1007/s00246-005-0992-6
|
[7]
|
Andreasen, J.B., Johnsen, S.P. and Ravn, H.B. (2008) Junctional Ectopic Tachycardia after Surgery for Congenital Heart Disease in Children. Intensive Care Medicine, 34, 895-902. https://doi.org/10.1007/s00134-007-0987-2
|
[8]
|
Grosse-Wortmann, L., Kreitz, S., Kreitz, R.G., Vazquez-Jimenez, J.F., Messmer, B.J., von Bernuth, G., et al. (2010) Prevalence of and Risk Factors for Perioperative Arrhythmias in Neonates and Children after Cardiopulmonary Bypass: Continuous Holter Monitoring before and for Three Days after Surgery. Journal of Cardiothoracic Surgery, 5, Article No. 85. https://doi.org/10.1186/1749-8090-5-85
|
[9]
|
Gebauer, R.A., Paech, C., Kolterer, B., Daehnert, I. and Kostelka, M. (2011) Postoperative Junctional Ectopic Tachycardia. Clinical Research in Cardiology, 100, 857-858.
|
[10]
|
Smith, A.H., Owen, J., Borgman, K.Y., Fish, F.A. and Kannankeril, P.J. (2011) Relation of Milrinone after Surgery for Congenital Heart Disease to Significant Postoperative Tachyarrhythmias. The American Journal of Cardiology, 108, 1620-1604.
https://doi.org/10.1016/j.amjcard.2011.07.023
|
[11]
|
Abelaziz, O. and Deraz, S. (2014) Anticipation and Management of Junctional Ectopic Tachycardia in Postoperative Cardiac Surgery: Single Center Experience with High Incidence. Annals of Pediatric Cardiology, 7, 19-24.
https://doi.org/10.4103/0974-2069.126543
|
[12]
|
Borgman, K.Y., Smith, A.H., Owen, J.P., Fish, F.A. and Kannankeril, P.J. (2011) A genetic Contribution to Risk for Postoperative Junctional Ectopic Tachycardia in Children Undergoing Surgery for Congenital Heart Disease. Heart Rhythm, 8, 1900-1904. https://doi.org/10.1016/j.hrthm.2011.06.033
|
[13]
|
DiFrancesco, D. and Camm, J.A. (2004) Heart Rate Lowering by Specific and Selective If Current Inhibition with Ivabradine: A New Therapeutic Perspective in Cardiovascular Disease. Drugs, 64, 1757-1765.
https://doi.org/10.2165/00003495-200464160-00003
|
[14]
|
Biel, M., Wahl-Schott, C., Michalakis, S. and Zong, X. (2009) Hyperpolarization- Activated Cation Channels: from Genes to Function. Physiological Reviews, 89, 847-885. https://doi.org/10.1152/physrev.00029.2008
|
[15]
|
Shi, W.-S., Wymore, R., Yu, H.-G., Wu, J.-Y., Wymore, R.T., Pan, Z.-M., et al. (1999) Distribution and Prevalence of Hyperpolarization-Activated Cation Channel (HCN) mRNA Expression in Cardiac Tissues. Circulation Research, 85, e1-e6.
https://doi.org/10.1161/01.RES.85.1.e1
|
[16]
|
Liu, J., Noble, P.J., Xiao, G.-S., Abdelrahman, M., Dobrzynski, H., Boyett, M.R., et al. (2008) Role of Pace Making Current in Cardiac Nodes: Insights from a Comparative Study of Sinoatrial Node and Atrioventricular Node. Progress in Biophysics and Molecular Biology, 96, 294-304.
https://doi.org/10.1016/j.pbiomolbio.2007.07.009
|
[17]
|
Horsthuis, T., Buermans, H.P., Brons, J.F., Verkerk, A.O., Bakker, M.L., Wakker, V., et al. (2009) Gene Expression Profiling of the Forming Atrioventricular Node Using a Novel Tbx3-Based Node-Specific Transgenic Reporter. Circulation Research, 105, 61-69. https://doi.org/10.1161/CIRCRESAHA.108.192443
|
[18]
|
Andrikopoulos, G., Dasopoulou, C., Sakellariou, D., Tzeis, S., Koulouris, S., Kranidis, A., et al. (2006) Ivabradine: A Selective If Current Inhibitor in the Treatment of Stable Angina. Recent Patents on Cardiovascular Drug Discovery, 1, 277-282.
|
[19]
|
Guglin, M. (2012) Heart Rate Reduction in Heart Failure: Ivabradine or Beta Blockers? Heart Failure Reviews, 18, 517-528. https://doi.org/10.1007/s10741-012-9347-6
|
[20]
|
McMurray, J.J., Adamopoulos, S., Anker, S.D., Auricchilo, A., Bohm, M., Dickstein, K., et al. (2012) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in Collaboration with the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure, 14, 803-869.
|
[21]
|
Traynor, K. (2015) Ivabradine Approved for Stable Chronic Heart Failure. American Journal of Health-System Pharmacy, 72, 896.
https://doi.org/10.2146/news150037
|
[22]
|
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., et al. (2013) 2013 ESC Guidelines on the Management of Stable Coronary Artery Disease: The Task Force on the Management of stable Coronary Artery Disease of the European Society of Cardiology. European Heart Journal, 34, 2949-3003. https://doi.org/10.1093/eurheartj/eht296
|
[23]
|
Benezet-Mazuecos, J., Rubio, J.M., Farre, J., Quinones, M.A., Sanchez-Borque, P. and Macia, E. (2013) Long-Term Outcomes of Ivabradine in Inappropriate Sinus Tachycardia Patients: Appropriate Efficacy or Inappropriate Patients. Pacing and Clinical Electrophysiology, 36, 830-836. https://doi.org/10.1111/pace.12118
|
[24]
|
Verrier, R.L., Bonatti, R., Silva, A.F., Batatinha, J.A., Nearing, B.D., Liu, G., et al. (2014) If Inhibition in the Atrioventricular Node by Ivabradine Causes Rate-Dependent Slowing of Conduction and Reduces Ventricular Rate during Atrial Fibrillation. Heart Rhythm, 11, 2288-2296.
|
[25]
|
Verrier, R.L., Silva, A.F., Bonatti, R., Batatinha, J.A., Nearing, B.D., Liu, G., et al. (2015) Combined Actions of Ivabradine and Ranolazine Reduce Ventricular Rate during Atrial Fibrillation. Journal of Cardiovascular Electrophysiology, 26, 329-335.
https://doi.org/10.1111/jce.12569
|
[26]
|
Bohora, S., Lokhandwala, Y., Parekh, P. and Vasavda, A. (2011) Reversal of Tachy cardiomyopathy Due to Left Atrial Tachycardia by Ivabradine. Journal of Cardiovascular Electrophysiology, 22, 340-342.
https://doi.org/10.1111/j.1540-8167.2010.01860.x
|
[27]
|
Nguyen, L.S., Squara, P., Amour, J., Carbognani, D., Bouabdallah, K., Thierry, S., et al. (2018) Intravenous Ivabradine versus Placebo in Patients with Low Cardiac Output Syndrome Treated by Dobutamine after Elective Coronary Artery Bypass Surgery: A Phase 2 Exploratory Randomized Controlled Trial. Critical Care, 22, 193. https://doi.org/10.1186/s13054-018-2124-8
|
[28]
|
Al-Ghamdi, S., Al-Fayyadh, M.I. and Hamilton, R.M. (2013) Potential New Indication for Ivabradine: Treatment of a Patient with Congenital Junctional Ectopic Tachycardia. Journal of Cardiovascular Electrophysiology, 24, 822-824.
https://doi.org/10.1111/jce.12081
|
[29]
|
Dieks, J.K., Klehs, S., Müller, M.J., Paul, T. and Krause, U. (2016) Adjunctive Ivabradine in Combination with Amiodarone: A Novel Therapy for Pediatric Congenital Junctional Ectopic Tachycardia. Heart Rhythm, 13, 1297-1302.
https://doi.org/10.1016/j.hrthm.2016.03.015
|
[30]
|
Kumar, V., Kumar, G., Joshi, S. and Sharma, V. (2017) Ivabradine for Junctional Ectopic Tachycardia in Post Congenital Heart Surgery. Indian Heart Journal, 69, 666-667. https://doi.org/10.1016/j.ihj.2017.09.007
|
[31]
|
Camm, A.J. and Lau, C.P. (2003) Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology. Drugs in R&D, 4, 83-89.
https://doi.org/10.2165/00126839-200304020-00001
|
[32]
|
Manz, M., Reuter, M., Lauck, G., Omran, H. and Jung, W. (2003) A Single Intravenous Dose of Ivabradine, a Novel If Inhibitor, Lowers Heart Rate but Does not Depress Left Ventricular Function in Patients with Left Ventricular Dysfunction. Cardiology, 100, 149-155. https://doi.org/10.1159/000073933
|
[33]
|
Swedberg, K., Komajda, M., Bohm, M., Borer, J.S., Ford, I., Dubost-Brama, A., et al. (2010) Ivabradine and Outcomes in Chronic Heart Failure (SHIFT): A Randomised Placebo-Controlled Study. The Lancet, 376, 875-885.
https://doi.org/10.1016/S0140-6736(10)61198-1
|